Core Viewpoint - E Fund has received approval from the China Securities Regulatory Commission to establish a company in Macau, aiming to enhance its asset management services for investors in the region [1] Group 1: Company Establishment - E Fund plans to establish a company named E Fund Investment Fund Management (Macau) Co., Ltd., focusing on providing asset management and related services to investors in Macau and surrounding areas [1] - The company will submit an application to the Macau Financial Management Bureau for formal approval after receiving regulatory backing [1] Group 2: Strategic Partnerships - In August 2024, E Fund signed a memorandum of cooperation with Itaú Asset Management in Brazil, indicating a strategic partnership to enhance cross-border financial services [1] - A product linked to E Fund's MSCI China A50 Connect ETF (code: SILK11) has been listed on the Brazilian Securities and Futures Exchange, showcasing the collaboration's immediate outcomes [1] Group 3: Market Positioning - The establishment of the Macau company will enable E Fund to better position itself within the Guangdong-Hong Kong-Macau Greater Bay Area, facilitating innovation in cross-border financial products and services [1] - E Fund aims to improve its global asset allocation capabilities and client service for both domestic and international investors, striving to become a leading investment institution [1]

Group 1 - Dongwu Fund Management Co., Ltd. announced a change in its chairman on August 9, 2023 [1] - The new chairman, Xue Zhen, will assume the position on August 7, 2025, succeeding Ma Zhenya, who is transitioning to a senior supervisory role due to age [2] - Dongwu Fund was established on September 2, 2004, with a registered capital of 100 million yuan, and its business scope includes fund raising, fund sales, asset management, and other activities permitted by the China Securities Regulatory Commission [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 富国中证港股通高股息投资交易型开放式指数证券投资基金上市交易公告书提示性公告 本公司董事会及董事保证基金上市交易公告书所载资料不存在虚假记载、误导性陈述或重大遗漏，并对 其内容的真实性、准确性和完整性承担个别及连带责任。 富国中证港股通高股息投资交易型开放式指数证券投资基金（基金简称"富国中证港股通高股息投资 ETF"，场内简称"港股通红利ETF富国"，交易代码：159277）将于2025年8月14日在深圳证券交易所上 市，上市交易公告书全文于2025年8月11日在本公司网站（www.fullgoal.com.cn）和中国证监会基金电 子披露网站（http://eid.csrc.gov.cn/fund）披露，供投资者查阅。如有疑问可拨打本公司客服电话（400- 888-0688）咨询。 本基金管理人承诺以诚实信用、勤勉尽责的原则管理和运用基金资产，但不保证本基金一定盈利，也不 保证最低收益。请充分了解本基金的风险收益特征，审慎做出投资决定。 特此公告。 富国基金管理有限公司 2025年8月11日 富国基金管理有限公司关于以通讯方式召开富国 中证通信设备主题交易 ...

经历三年调整期，2025年主动管理权益基金收益回升势头强劲。据wind数据，截至8月7日，95%主动权 益基金（剔除2025年之后成立，下同）年内取得正收益，平均收益突破15%。业绩榜单上，医药行业主 题基金成为最大赢家，4只年内收益翻倍主动权益基金（只计算初始份额，下同）均属其列。 百亿主动权益基金经理动态尤为引人关注。Wind数据显示，截至2025年上半年末，有90名主动权益基 金经理管理规模超百亿元，易方达基金张坤以超500亿元领衔。Wind指数显示，截至8月7日，有86名百 亿主动权益基金经理偏股型指数年内收益为正，汇添富基金张韡、永盈基金张璐收益分别以65.8%、 53.4%领跑；仅广发基金王明旭、郑澄然，兴证全球基金董理、景顺长城刘彦春四人偏股型指数年内收 益为负，王明旭偏股型指数年内收益-7.4%，收益垫底。 年内95%主动权益基金收益为正，4只翻倍 | 基金简称 | 基金成立日 | 基金规模 | 截至2025年6月末 | | 年内收益率 | 置等经理(现任) | 基金管理人 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | ...

Group 1 - The core point of the announcement is the appointment of He Kang as an additional fund manager for the Zheshang Dayinjin Money Market Fund [1][4] - He Kang joined Zheshang Fund Management Co., Ltd. in July 2022 and is currently part of the fixed income department [2] - The Zheshang Dayinjin Money Market Fund A and B were established on December 1, 2016, with cumulative returns of 22.18% and 24.70% respectively as of June 16, 2025 [2] Group 2 - As of March 31, 2025, the total scale of the fund is 9.895 billion yuan [2] - The fund is managed by multiple fund managers, including He Kang, Zhao Liuyan, and Niu Guanqun [4] - The announcement is made in accordance with the "Measures for the Disclosure of Information on Publicly Raised Securities Investment Funds" [4]

6月30日晚，公募基金上半年业绩排名出炉。 数据显示，截至6月30日22时，剔除需T+2日披露净值的QDII产品后，中信建投（601066）北交所 精选两年定开、长城医药产业精选、华夏北交所创新中小企业精选两年定开跻身2025年上半年公募基金 业绩前三名，上半年涨幅分别达82.45%、75.18%、72.16%（主代码口径，有多个基金份额的默认为A份 额涨幅）。 从近三年、近五年、近十年维度看，截至2025年年中的业绩"冠军"分别为华夏北交所创新中小企业 精选两年定开、金元顺安元启、华商新趋势优选，相应区间收益率分别为175.64%、297.96%、 361.6%。 北交所主题基金表现亮眼 创新药基金集体发力 除北交所主题基金外，主投医药方向尤其是创新药板块的基金表现亮眼。数据显示，全市场业绩排 名前十的基金中，2025年一季度末主投医药的基金共有6只，多投向医药板块中的创新药细分领域。 由新锐基金经理梁福睿管理的长城医药产业精选成为上半年业绩亚军。该基金一季度末前十大重仓 股分别为泽璟制药、信达生物、益方生物、康弘药业（002773）、热景生物、一品红（300723）、康方 生物、诺诚健华、科伦博泰生物、再 ...

公告送出日期：2025年8月8日 1. 公告基本信息 ■ 2.其他需要提示的事项 （1）为了满足广大投资者的投资需求，根据相关法律法规、监管规定及基金合同的相关规定，基金管 理人决定自2025年8月8日起取消东海祥瑞债券型证券投资基金（以下简称"本基金"）对机构投资者A类 份额和C类份额的申购限额，恢复其正常的大额申购。自2025年8月8日起，机构投资者申购本基金各类 基金份额均不限额。 （2）本公告涉及上述业务的最终解释权归本公司所有。 （3）投资者欲了解本基金的其他情况，可通过本公司官网https://www.donghaifunds.com查阅本基金的 相关法律文件。 特此公告。 东海基金管理有限责任公司 2025年8月8日 东海基金管理有限责任公司关于旗下部分基金新增国泰海通证券股份有限公司为代销机构并开通定投业 务、转换业务及参加费率优惠的公告 根据东海基金管理有限责任公司（以下简称"本公司"）与国泰海通证券股份有限公司（以下简称"国泰 海通证券"）签署的销售协议和相关业务准备情况，自2025年8月11日起，本公司旗下部分基金新增国泰 海通证券为代销机构并开通相关基金定投业务、转换业务及参加费率优惠 ...

Group 1 - The core viewpoint of the articles indicates that the restoration of VAT on bond interest will create a temporary advantage for existing bonds (old bonds) over newly issued bonds (new bonds), leading to significant market fluctuations [1][2] - The yield of 10-year government bonds fell to around 1.68% before rising back above 1.7% in the afternoon, reflecting the market's reaction to the new tax policy [1] - Institutions predict that the yield spread between old and new bonds could reach 5 to 10 basis points (BP), with new bond yields likely increasing more than the decrease in old bond yields [2][3] Group 2 - Different institutions will be affected variably by the tax policy change, with banks facing the highest tax burden at 6.34% for new bonds, while asset management products will face a lower rate of 3.26% [3] - The tax burden on financial institutions may lead to a shift in investment strategies, with public funds potentially gaining a relative tax advantage, encouraging more bank funds to invest in bonds through public funds [3] - The long-term direction of the bond market will still be determined by fundamental factors, despite short-term trading opportunities created by the new tax policy [4]

Core Viewpoint - The assessment criteria for guiding funds towards sub-funds have become increasingly stringent, with new penalties for failing to meet investment return and exit plans [2][3][4]. Group 1: Fund Management Fees - Recent regulations have changed the management fee structure, limiting it to a maximum of 2% of the actual investment amount rather than the subscribed amount, which may lead to a decrease in overall management fees [4][5]. - Many GP institutions are facing deductions in management fees due to unsatisfactory performance evaluations, with some required to return previously received fees if performance metrics are not met [3][4]. - The industry is experiencing a downward trend in management fees, as new guidelines emphasize actual contributions over subscribed amounts, indicating a shift in how fees are calculated [5]. Group 2: Exit Strategies and Challenges - The current market conditions have created a backlog of projects awaiting exit, with a heavy reliance on IPOs for exits, which is becoming increasingly difficult due to a slowdown in IPO activity [6][9]. - Many GPs are struggling to meet the required DPI (Distributions to Paid-In) ratio of 1, which is critical for securing agreement from LPs for extensions on fund timelines [7][9]. - There are instances of forced exit clauses in agreements, allowing guiding funds to mandate exits under specific conditions, which adds pressure on GPs to perform [8][9]. Group 3: Relationship Between GPs and LPs - The relationship between GPs and LPs is strained, particularly with state-owned LPs who have strict requirements for performance and exit timelines, leading to potential legal actions against GPs [9][10]. - Some regions are exploring solutions to ease the pressure on GPs, such as extending the duration of fund management to accommodate current market conditions [11]. - The need for a more flexible approach in assessing GPs' performance and allowing for extensions is recognized as essential for maintaining healthy relationships in the investment ecosystem [11].

成立近17年来，华夏香港一直致力于打造一个差异化的中资机构。 金融产品创新，如同"拿着锤子找钉子"，也如同"找准钉子造锤子"的过程。这意味着开拓者要兼具前瞻 视野以定位潜在需求，以及拆解难点、构建创新动能的能力。华夏基金（香港）近年来正是如此践行： 放弃"寻找更好的蜡烛"，选择"点亮电灯"，在新兴赛道上持续破局。 在华夏香港CEO甘添看来，新技术革命对金融业并非锦上添花，而是形态重塑。正如十几年前，在没人 可以想象互联网将以全天候、跨地域、效率革命的线上业态颠覆大众消费习惯时，就有一批科技企业致 力于创新产品改变生活。当下中国香港市场的创新土壤，为资管机构提供了不可多得的战略机遇。华夏 香港作为创新的笃行者，在拥有全面资产类别的背景下，每一阶段性的战略方向都充满前瞻性，打造了 多只全球首发、亚洲首发、中国香港市场首发的产品。 甘添看好离岸人民币债券市场未来三到五年的爆发式增长，华夏香港已抢占布局先机：香港首只以人民 币计价、跨市场、纯投资级别的人民币债券公募基金正是来自华夏香港。甘添预测，离岸人民币资金池 有望在2030年达约5万亿元规模，而点心债（离岸人民币债券）作为核心载体面临历史性机遇。 甘添，华夏基金 ...